Jeffrey D. Bray

U.S. Food and Drug Administration Approval: Carfilzomib for the Treatment of Multiple Myeloma

Thomas M. Herndon, Albert Deisseroth, Edvardas Kaminskas et al. · Clinical Cancer Research · 2013 · 241 citations

Medicine, Pharmacology, Pharmacotherapy +17

Development of a Small-Molecule Serum- and Glucocorticoid-Regulated Kinase-1 Antagonist and Its Evaluation as a Prostate Cancer Therapeutic

Andrea B. Sherk, Daniel E. Frigo, Christine G. Schnackenberg et al. · Cancer Research · 2008 · 214 citations · Full text

Medicine, Molecular Biology, Oncology +17

A Structural and in Vitro Characterization of Asoprisnil: A Selective Progesterone Receptor Modulator

Kevin P. Madauss, Eugene T. Grygielko, Su-Jun Deng et al. · Molecular Endocrinology · 2007 · 149 citations

Medicine, Endocrinology, Pharmacology +17

EADB: An Estrogenic Activity Database for Assessing Potential Endocrine Activity

Jie Shen, Lei Xu, Hong Fang et al. · Toxicological Sciences · 2013 · 76 citations · Full text

Life Sciences, Endocrinology, Toxicology +16

Quantitative analysis of gene regulation by seven clinically relevant progestins suggests a highly similar mechanism of action through progesterone receptors in T47D breast cancer cells

Jeffrey D. Bray, Scott A. Jelinsky, Radhika P Ghatge et al. · The Journal of Steroid Biochemistry and Molecular Biology · 2005 · 60 citations

Life Sciences, Endocrinology, Oncology +13